Table 2 Demographic and Clinical Characteristics of participants in the study of tryptophan metabolism

Number

51

120

Age (years)

10.75 ± 2.20^a

9.91 ± 5.33^a

0.280

Gender (male)

31(61%)

68(57%)

0.460

Clinical characteristics

 Course (months)

6.00 ± 23.00^b

 Duration attacks (hours)

3.00 ± 4.00^b

 VAS score

6.00 ± 2.00^b

 Frequency (times/month)

18.00 ± 18.00^b

 Ictal phase

33(65%)

 Aura

11(22%)

Aura

 Visual aura

8(16%)

 Sensory aura

4(8%)

Concomitant symptoms

 Nausea

33(65%)

 Vomiting

18(35%)

 Photophobia

20(39%)

 Phonophobia

20(39%)

Pain site

 Unilateral temporal

7(14%)

 Bilateral temporal

16(31%)

 Frontal

25(49%)

 Parietal

10(20%)

 Occipital

9(18%)